We are delighted for you to participate in the 3rd Annual Neuroscience in Intensive Care International Symposium America (NICIS-America). The upcoming meeting will be held on March 8-9, 2019 in Washington DC and is titled “Neurologic Biomarkers in Critical Care: Physiology, Treatment and Recovery”. Neurologic biomarkers are quantifiable biological signatures identified in molecular assays of blood or CSF, neurophysiological recordings, and structural or functional changes captured with neuroimaging. Biomarkers are the basis for neurologic injury detection, diagnostic classification, treatment selection, and prognostication. In the intensive care unit, the care of patients with acute brain injury is increasingly reliant on the analysis of appropriately selected biomarkers. The conference will include sessions on physiological biomarkers, cellular biomarkers, imaging biomarkers, and biomarkers derived from high throughput molecular sequencing. Additional sessions will focus on the role of biomarkers in detection and diagnosis, treatment selection, biomarkers of impending neurological crises, and biomarkers for recovery and prognostication. The keynote speakers include Maiken Nedergard, a pioneering neuroscientist who has discovered the ‘glymphatic system’ in the brain, as well as Ramon Diaz-Arrastia, one of the principal investigators of the Track-TBI study and an internationally recognized investigator traumatic brain injury.
Join our mailing list today and receive our latest newsletter delivered straight to your inbox!